BrYet
Cambridge, United States· Est. 2021
We are focused on developing drugs for the treatment and cure of otherwise incurable cancers using multi-component therapeutics to target transport phenotypes.
Private Company
Funding information not available
About
We are focused on developing drugs for the treatment and cure of otherwise incurable cancers using multi-component therapeutics to target transport phenotypes.
Drug Delivery